The role of azithromycin in acute exacerbation of asthma in childre

Not Applicable

• Conditions: Health Condition 1: J459- Other and unspecified asthma

• Registration Number: CTRI/2023/04/051280
• Lead Sponsor: Rimpi Konchikol Momin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Children between the ages of completed 5 years and completed 18 years hospitalized with acute exacerbation of asthma

Exclusion Criteria

1. Use of antibiotics during the 30 days prior to enrolment in study and documented fever (temp >38 degree celsius)

2. contraindication for use of azithromycin

3. Significant medical co-morbidity: Congenital and acquired heart disease, chronic lung disease, tuberculosis, cholestatic jaundice

4. Life threatening exacerbation requiring PICU admissions.

5. children already enrolled in the study and presenting within 60 days of discharge from hospital.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Average Length of hospital stayTimepoint: Length of hospital stay

Secondary Outcome Measures

Name	Time	Method
1. number of Emergency Department re-visit for troublesome asthma symptoms within next 60 days after discharge from hospital. <br/ ><br>2.Persistence of symptoms (cough and/or subjective breathlessness) beyond 1 week after discharge from hospital. <br/ ><br>3.Time to next exacerbation during 60 days after discharge. <br/ ><br>4.Admission to ICU. <br/ ><br>5.Change in Pulmonary Index Score during admission.Timepoint: 60 days